ZA200107074B - Pharmaceutical composition based on polyaromatic compounds. - Google Patents

Pharmaceutical composition based on polyaromatic compounds.

Info

Publication number
ZA200107074B
ZA200107074B ZA200107074A ZA200107074A ZA200107074B ZA 200107074 B ZA200107074 B ZA 200107074B ZA 200107074 A ZA200107074 A ZA 200107074A ZA 200107074 A ZA200107074 A ZA 200107074A ZA 200107074 B ZA200107074 B ZA 200107074B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
composition based
polyaromatic compounds
polyaromatic
compounds
Prior art date
Application number
ZA200107074A
Other languages
English (en)
Inventor
Evelyne Deflourne
Bontemps-Subielos Nathalie
Francis Darro
Jean Bastide
Robert Kiss
Armand Frydman
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of ZA200107074B publication Critical patent/ZA200107074B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200107074A 1999-03-18 2001-08-27 Pharmaceutical composition based on polyaromatic compounds. ZA200107074B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903390A FR2790954B1 (fr) 1999-03-18 1999-03-18 Composition pharmaceutique a base de composes polyaromatiques

Publications (1)

Publication Number Publication Date
ZA200107074B true ZA200107074B (en) 2002-08-27

Family

ID=9543359

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107074A ZA200107074B (en) 1999-03-18 2001-08-27 Pharmaceutical composition based on polyaromatic compounds.

Country Status (18)

Country Link
US (1) US6583150B1 (fr)
EP (1) EP1161432A1 (fr)
JP (1) JP2002539212A (fr)
KR (1) KR20020001778A (fr)
CN (1) CN1344269A (fr)
AU (1) AU778375B2 (fr)
BR (1) BR0009113A (fr)
CA (1) CA2361810A1 (fr)
CZ (1) CZ20013348A3 (fr)
FR (1) FR2790954B1 (fr)
HU (1) HUP0200408A3 (fr)
IL (1) IL145127A0 (fr)
NO (1) NO20014450L (fr)
NZ (1) NZ513853A (fr)
PL (1) PL350899A1 (fr)
SK (1) SK12282001A3 (fr)
WO (1) WO2000055160A1 (fr)
ZA (1) ZA200107074B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797443B1 (fr) * 1999-08-13 2003-10-31 Lafon Labor Procede de prepartion de quinoleine-5,8-diones
WO2017059401A2 (fr) * 2015-10-01 2017-04-06 Duke University Ligands du récepteur des androgènes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB695752A (en) 1950-06-15 1953-08-19 Borg Warner Improvements in or relating to rotary pumps and bushings for rotary pumps
US5182287A (en) * 1989-11-03 1993-01-26 Harbor Branch Oceanographic Bioactive heterocycle alkaloids and methods of use
ES2088822B1 (es) * 1994-02-24 1997-08-01 Univ Madrid Complutense Nuevos derivados antraquinonicos con actividad antitumoral y sus aplicaciones.
GB9708751D0 (en) * 1997-04-29 1997-06-25 Univ Madrid Complutense New cytotoxic analogues of marine natural products derivatives of the pyrido (2,3,4-K1) acridine ring systems
GB9810998D0 (en) 1998-05-21 1998-07-22 Univ Madrid Complutense Antitumour 1,5-diazaanthraquinones

Also Published As

Publication number Publication date
CZ20013348A3 (cs) 2002-05-15
FR2790954B1 (fr) 2003-08-08
AU778375B2 (en) 2004-12-02
KR20020001778A (ko) 2002-01-09
FR2790954A1 (fr) 2000-09-22
CN1344269A (zh) 2002-04-10
JP2002539212A (ja) 2002-11-19
HUP0200408A2 (hu) 2002-07-29
BR0009113A (pt) 2001-12-18
EP1161432A1 (fr) 2001-12-12
NO20014450D0 (no) 2001-09-13
PL350899A1 (en) 2003-02-10
AU3437400A (en) 2000-10-04
SK12282001A3 (sk) 2002-08-06
HUP0200408A3 (en) 2003-03-28
NZ513853A (en) 2001-09-28
CA2361810A1 (fr) 2000-09-21
WO2000055160A1 (fr) 2000-09-21
US6583150B1 (en) 2003-06-24
NO20014450L (no) 2001-11-16
IL145127A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
HK1045650A1 (en) Pharmaceutical composition.
ZA993338B (en) Pharmaceutical formulations.
MXPA03000771A (es) Nuevas composiciones farmaceuticas.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200743B (en) Preserved pharmaceutical formulations.
ZA200108000B (en) Cosmetic compounds.
HK1027957A1 (en) Pharmaceutical composition.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
HK1038884A1 (en) Medicinal compositions.
ZA200203486B (en) Novel pharmaceutical compositions.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
ZA200108968B (en) New compounds.
ZA200005510B (en) Pharmaceutical composition.
ZA200000857B (en) Pharmaceutical composition.
ZA200203707B (en) Pharmaceutical combinations.
ZA989680B (en) Pharmaceutical composition.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
HK1046642A1 (en) Novel diphenylethylene compounds.
HK1022853A1 (en) Pharmaceutical compositions.
HK1040488A1 (en) Pharmaceutical formulations.
ZA987392B (en) Pharmaceutical composition.
HK1044117A1 (en) Pharmaceutical composition.
ZA200110454B (en) Pharmaceutical complex.
ZA200203311B (en) Pharmaceutical carrier formulation.